Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Cash from Financing Activities (2020 - 2025)

Cytek Biosciences' Cash from Financing Activities history spans 6 years, with the latest figure at -$1.2 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 66.32% year-over-year to -$1.2 million; the TTM value through Dec 2025 reached -$13.4 million, up 15.11%, while the annual FY2025 figure was -$13.4 million, 15.11% up from the prior year.
  • Cash from Financing Activities reached -$1.2 million in Q4 2025 per CTKB's latest filing, down from $1.9 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $217.1 million in Q3 2021 to a low of -$33.8 million in Q4 2023.
  • Average Cash from Financing Activities over 5 years is $7.8 million, with a median of $17000.0 recorded in 2021.
  • Peak YoY movement for Cash from Financing Activities: soared 22547.06% in 2022, then crashed 5438.06% in 2023.
  • A 5-year view of Cash from Financing Activities shows it stood at $17000.0 in 2021, then skyrocketed by 22547.06% to $3.8 million in 2022, then plummeted by 976.73% to -$33.8 million in 2023, then soared by 89.22% to -$3.6 million in 2024, then soared by 66.32% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Cash from Financing Activities are -$1.2 million (Q4 2025), $1.9 million (Q3 2025), and -$2.6 million (Q2 2025).